1. bookVolume 19 (2018): Issue 3 (September 2018)
Journal Details
License
Format
Journal
First Published
23 Apr 2014
Publication timeframe
4 times per year
Languages
English
Copyright
© 2020 Sciendo

Preclinical and Clinical Evidence of Safety of Antiviral Drug with Immunomodulatory Activity

Published Online: 29 Oct 2018
Page range: 271 - 276
Received: 11 Aug 2018
Accepted: 12 Sep 2018
Journal Details
License
Format
Journal
First Published
23 Apr 2014
Publication timeframe
4 times per year
Languages
English
Copyright
© 2020 Sciendo

Antiviral drug Kagocel is widely used in Russia for prevention and treatment of acute respiratory infection, influenza, and herpes. The drug belongs to the group of interferon inductors. The article contains the review and analytical evaluation of safety of antiviral drug Kagocel. Kagocel is registered in the Russian Federation and some CIS countries and refers to the group of interferon inducers. This is a chemical compound of carboxymethyl cellulose and low-molecular natural polyphenol gossypol common in cotton-plant (Gossypium spp.) which protects the plant from depredators and diseases. Authors pay a special attention to the analysis and generalization of data from preclinical and clinical studies including the control of related substances. Absence of free gossypol impurities guaranteed by highly sensitive and specific quality control methods. Preclinical studies data was analyzed and the results were presented with focus on reproductive safety of Kagocel® in immature and mature animals.. No negative effect on animals’ reproductive function was revealed including spermatogenesis and generative function. No long-term product effect on reproductive system or next generations of animals was recorded both at therapeutic doses and at doses 10 times their exceeding. The safety of the drug demonstrated on data obtained from numerous clinical trials, including those involving children aged 2 years and older. Th is confirms the safety of antiviral drug Kagocel usage in clinical practice, including pediatrics.

Keywords

1. Lvov, D. et. al. (2016) Virological, epidemiological, clinic, and molecular genetic features of the influenza epidemic in 2015-2016: prevailing of the influenza A(H1N1)09 pdm virus in Russia and countries of the Northern hemisphere. Voprosy Virusologii, 61(4), 159-166Search in Google Scholar

2. Goncharova, O. V. (2016). Phytotherapy in treatment and rehabilitation of children recovering from acute respiratory viral infections. Medical Council, 1(1), 58–62.Search in Google Scholar

3. Ulasevich, A., Jacobs, S., Mbangdadji, D., van Over, M., & Steffens, L. (2017). Understanding Flu Vaccination in a Competitive Context. Social Marketing Quarterly, 23(4), 320–334.10.1177/1524500417718141Open DOISearch in Google Scholar

4. Trieu, M. C., Zhou, F., Lartey, S. L., Sridhar, S., Mjaa-land, S., & Cox, R. J. (2018) Augmented CD4(+) T-cell and humoral responses after repeated annual influenza vaccination with the same vaccine component A/H1N1pdm09 over 5 years. NPJ. Vaccines. 3, 37.Search in Google Scholar

5. Blakely, S. A. R. (n.d.). Research Approaches to Special Preclinical Safety and Toxicological Evaluations. Nutraceuticals, 45–53.Search in Google Scholar

6. Mishra, S., & Kumar, H. (2017). Balancing anti-viral innate immunity and immune homeostasis. Cellular and Molecular Immunology. doi:10.1038/cmi.2017.9810.1038/cmi.2017.98Open DOISearch in Google Scholar

7. Mänz, B., Dornfeld, D., Götz, V., Zell, R., Zimmer-mann, P., Haller, O. Schwemmle, M. (2013). Pandemic Influenza A Viruses Escape from Restriction by Human MxA through Adaptive Mutations in the Nucleo-protein. PLoS Pathogens, 9(3), e1003279. doi:10.1371/journal.ppat.1003279Search in Google Scholar

8. Hamming, O. J., Terczyńska-Dyla, E., Vieyres, G., Dijkman, R., Jørgensen, S. E., Akhtar, H. Hartmann, R. (2013). Interferon lambda 4 signals via the IFNλ receptor to regulate antiviral activity against HCV and coronaviruses. The EMBO Journal, 32(23), 3055–3065. doi:10.1038/emboj.2013.232Search in Google Scholar

9. Ershov F.I. Narovlyansky A.N. (2015) Use of interferon inducers in viral infections. Voprosi virusologii; 60 (2): 54-10. PMID:26182650;Search in Google Scholar

10. Galegov, G. A., et al. (2002) The effect of Kagocel on herpes virus reproduction. Voprosy virusologii 47(4) 42-44.12271726Search in Google Scholar

11. Sologub, T. V., & Tsvetkov, V. V. (2017). Kagocel in the therapy of influenza and acute respiratory viral infections: Data analysis and systematization from the results of preclinical and clinical trials. Terapevticheskii Arkhiv, 89(8), 113.Search in Google Scholar

12. Myat, T. S., & Tetsuka, M. (2016). Gossypol inhibits LH-induced steroidogenesis in bovine theca cells. Animal Science Journal, 88(1), 63–71.Search in Google Scholar

13. Warnsmann, V., Meyer, N., Hamann, A., Kögel, D., & Osiewacz, H. D. (2017). A novel role of the mitochondrial permeability transition pore in (−)-gossypol-induced mitochondrial dysfunction. Mechanisms of Ageing and Development. doi:10.1016/j.mad.2017.06.00410.1016/j.mad.2017.06.004Open DOISearch in Google Scholar

14. Keshmiri-Neghab, H., & Goliaei, B. (2013). Therapeutic potential of gossypol: An overview. Pharmaceutical Biology, 52(1), 124–128. doi: 10.3109/13880209.2013.83277610.3109/13880209.2013.832776Open DOISearch in Google Scholar

15. Yang, Z.-J., Ye, W.-S., Cui, G.-H., Guo, Y., & Xue, S.-P. (2004). Combined administration of low-dose gossypol acetic acid with desogestrel/mini-dose ethinylestradiol/testosterone undecanoate as an oral contraceptive for men. Contraception, 70(3), 203–211.10.1016/j.contraception.2004.02.019Open DOISearch in Google Scholar

16. Schwartze, E. W. (1926). Gossypol and cottonseed meal poisoning. Journal of Oil & Fat Industries, 3(5), 173–178.Search in Google Scholar

17. Lu, Y., Li, J., Dong, C.-E., Huang, J., Zhou, H.-B., & Wang, W. (2017). Recent advances in gossypol derivatives and analogs: a chemistry and biology view. Future Medicinal Chemistry, 9(11), 1243–1275.Search in Google Scholar

18. Xu, L., Yang, D., Wang, S., Tang, W., Liu, M., Chen, J., Lippman, M. E. (2004). 643 Radiosensitization of human prostate cancer by natural polyphenol inhibitor of Bcl-2/XL, (−)-gossypol, results in tumor regression. European Journal of Cancer Supplements, 2(8), 194. doi:10.1016/s1359-6349(04)80651-710.1016/S1359-6349(04)80651-7Open DOISearch in Google Scholar

19. Borovskaya, T. G. (2017). Safety of the Russian antiviral drug Kagocel. Terapevticheskii Arkhiv, 89(11), 93.Search in Google Scholar

20. Ye W et al. (2010). Induction of apoptosis by (-)-gossypol-enriched cottonseed oil in human breast cancer cells. International Journal of Molecular Medicine, 26(1), 113-119.Search in Google Scholar

21. Yang, J., Li, L.-L., Li, J.-R., Yang, J.-X., Zhang, F., Chen, G., Wu, S.-W. (2018). Synthesis and biological evaluation of water-soluble derivatives of chiral gossypol as HIV fusion inhibitors targeting gp41. Bioorganic & Medicinal Chemistry Letters, 28(1), 49–52. doi:10.1016/j.bmcl.2017.08.04910.1016/j.bmcl.2017.08.049Open DOISearch in Google Scholar

22. Tilyabaev, K. Z., Kamaev, F. G., Vypova, N. L., Yuldashev, A. M., Ibragimov, B. T., & Talipov, S. A. (2010). Synthesis, structures, and acute toxicity of gossypol nonsymmetrical aldehyde derivatives. Russian Journal of Bioorganic Chemistry, 36(3), 390–395.10.1134/S1068162010030167Open DOISearch in Google Scholar

23. Aoyama, K. (2008). Determination of Gossypol in Feeds by HPLC. Journal of the Food Hygienic Society of Japan (Shokuhin Eiseigaku Zasshi), 49(4), 303–307.10.3358/shokueishi.49.303Open DOISearch in Google Scholar

24. Habas, K., Brinkworth, M. H., & Anderson, D. (2017). In vitroresponses to knownin vivogenotoxic agents in mouse germ cells. Environmental and Molecular Mutagenesis, 58(2), 99–107.10.1002/em.22075Open DOISearch in Google Scholar

25. Gossypol as undesirable substance in animal feed - Scientific Opinion of the Panel on Contaminants in the Food Chain. EFSA Journal, 7(1), 908.Search in Google Scholar

26. Zhang, W., Huang, C., Xie, W., & Shen, L. (2014). Determination of gossypol in edible vegetable oil with high performance liquid chromatography-tandem mass spec-trometry. Chinese Journal of Chromatography, 32(6), 582.Search in Google Scholar

27. Borovskaya, T. G., Poluektova, M. E., Vychuzhanina, A. V., Mashanova, V. A., & Shchemerova, Y. A. (2017). Experimental Assessment of the Effect of Kagocel on Reproductive Function in Pubertal Male Rats. Bulletin of Experimental Biology and Medicine, 163(2), 214–217.Search in Google Scholar

28. Vinokurov, A. A. Hodgkin’s lymphoma and male fertility disorders. Klin. Onkogematol. 2013;6(3):258-273.Search in Google Scholar

29. Durnev, A. D., Smol’nikova, N. M., Skosureva, A. M., Nemova, E. P., Solomina, A. S., Shrede O. V., Gus’kova, T. A., Verstakova, O. L., & Syubaev, R.D. Methodical recommendations for preclinical study of reproductive toxicity of new drugs. Manual for Preclinical Studies of New Pharmacological Substances. Mironov AN, Bunatyan ND. Moscow, 2013. Part I. P. 80-93.Search in Google Scholar

30. Rybalkin, S. P., Konovalova, E. V., Guskova, T. A., & Savinova, T. B. Experimental evaluation of the effect of Kagocel on generative function in animals. Toksikol. Vestnik. 2013. 2: 33-38.Search in Google Scholar

31. Harlamov, F. S., Kladova, O. V., Uchaykin, V. F., Cheshik, S. G., Vartanyan, R. V., & Yablonskaya, K. P. (2015). Metapneumovirus and bokavirus respiratory infections in the structure of sars in children. Children infections, 14(2), 5–11.Search in Google Scholar

32. De Peyster, A., & Wang, Y. Y. (1993) Genetic toxicity studies of gossypol. Mutat. Res. 297(3), 293-312.Search in Google Scholar

Plan your remote conference with Sciendo